Neurotech Pharmaceuticals, Inc.
Cumberland, RI Doing business as Neurotech USA Corp
- UEI
- SSYBDBA61GV4
- CAGE
- 10UU1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 900 Highland Corporate Dr #101, Cumberland, RI 02864, USA
- Website
- neurotechpharmaceuticals.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $187,506 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $187,506 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Encelto implant for patient surgery | Veterans Integrated Service Network 19 (VHA) | $187,506 |
Similar vendors
About the company
Neurotech Pharmaceuticals, Inc., doing business as Neurotech USA Corp, is a for-profit pharmaceutical manufacturer selling specialty medical implants and pharmaceutical products to the Department of Veterans Affairs as a prime contractor under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), competing in full-and-open procurements with no set-aside designation.
The vendor holds positions on two active Federal Supply Schedule contracts under FSS-61-IB with the Veterans Integrated Service Network 12 (VISN 12), with a combined ceiling of $250 thousand through December 31, 2030, and has executed one delivery order against those vehicles. On February 27, 2026, VISN 19 awarded Neurotech a delivery order valued at $187,906.25 on a firm fixed-price basis for the provision of Encelto implants for patient surgery, completed March 6, 2026 and performed in Cumberland, Rhode Island. The short performance window reflects urgent clinical procurement need to support surgical procedures within the VA healthcare network. All three awards in the source footprint are FSS-61-IB multiple-award schedule vehicles; the vendor does not hold seats on broader government-wide acquisition contracts or agency-wide IDIQs.
Customer concentration is entirely within the Veterans Health Administration across two VISNs. VISN 12 accounts for two awards (combined potential value $250 thousand) and VISN 19 for one award ($188 thousand), representing 100% of recent activity across one federal agency and two regional service networks. The vendor's footprint is nascent — three total awards since July 2025 with combined potential value of $438 thousand, of which $188 thousand has been obligated. Activity shows two awards in 2026 against one in 2025, but the sample size and recency preclude characterization of sustained trajectory. All awards are classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC codes for drugs and biologicals, reflecting the vendor's core capability as a pharmaceutical and specialty medical-device manufacturer serving VA surgical and clinical supply chains. The vendor operates exclusively as a prime contractor with no documented sub-award relationships in the source footprint.
Quick answers
Is Neurotech Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Neurotech Pharmaceuticals, Inc.'s SAM.gov registration is active through March 26, 2027.
What is Neurotech Pharmaceuticals, Inc.'s CAGE code?
Neurotech Pharmaceuticals, Inc.'s CAGE code is 10UU1, and its Unique Entity ID (UEI) is SSYBDBA61GV4.
Which contract vehicles does Neurotech Pharmaceuticals, Inc. hold?
Neurotech Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Neurotech Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $187,506 to Neurotech Pharmaceuticals, Inc. in fiscal years 2023 through 2027.
What is Neurotech Pharmaceuticals, Inc.'s most recent federal award?
Neurotech Pharmaceuticals, Inc.'s most recent federal contract award is Encelto implant for patient surgery (36C25926F0121), from Veterans Integrated Service Network 19 (VHA), on February 27, 2026.
On GovTribe
See Neurotech Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors